Health

Plant-based food technology is revolutionizing the way we see food. Texture and flavour innovations combined with lower environmental and health costs support remarkable product growth to meet consumer demand. [more]

After its public listing last October, shares in Canbud appear poised to move higher as it executes on its three-pronged business model: 1) Hemp for cannabinoids (CBD) production, (2) Mushrooms for both psychedelic pharmaceuticals and non-psychedelic nutraceuticals, and (3) Plant-based products. [more]

Organic Garage’s FQ3/2021 revenue was $6.92 million, an increase of 21.6% year-over-year. Gross Profits remains steady above 30%. With improved revenue and previous cost-cutting measures, EBITDA was substantially higher at $0.69 million. [more]

Graphene-based products manufacturer sees increased demand driven by COVID-19 pandemic and reported its strongest quarter to date with revenue of US$1.2 million, a 497% increase. [more]

XORTX is a biopharmaceutical company focused on developing drugs that could reduce serum acid uric levels. An Initiation Equity Research Report on XORTX was published by eResearch on August 16, 2020. [more]

With the upswing in food retail due to the current COVID-19 health crisis, Organic Garage recognized revenue increases in the past two quarters of 19% and 29% year-over-year. We believe this sales trend should continue. The new Leaside store, opening next year, should boost revenue by 10-20% in 2021. [more]

Last month Amwell and GoodRx, two telehealth-focused companies, listed publicly through IPOs. Amwell raised $922M with a current market cap of $7.8B, while GoodRx raised $1.3B with a current market cap of $20B. [more]

In September, CloudMD announced a series of acquisitions to expand its telehealth services. CloudMD spent approximately $19M on three acquisitions, including Benchmark Systems, iMD Health Global, and Snapclarity. [more]